Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

To begin editing, click here or the Edit button above.

This page was last edited on 17 June 2021 at 12:12 (UTC).
By using this site, you agree to the Terms of Service and Privacy Policy. Idealogs® is a registered trademark of the Idealogical Foundation, Inc., a non-profit organization.
About
|
Contact
|
Docs
|
Developers
|
Donate
Idealogs Extension Icon